全文获取类型
收费全文 | 3550篇 |
免费 | 255篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 83篇 |
妇产科学 | 149篇 |
基础医学 | 424篇 |
口腔科学 | 11篇 |
临床医学 | 736篇 |
内科学 | 627篇 |
皮肤病学 | 45篇 |
神经病学 | 241篇 |
特种医学 | 59篇 |
外科学 | 334篇 |
综合类 | 52篇 |
一般理论 | 7篇 |
预防医学 | 569篇 |
眼科学 | 23篇 |
药学 | 230篇 |
中国医学 | 5篇 |
肿瘤学 | 192篇 |
出版年
2023年 | 16篇 |
2022年 | 12篇 |
2021年 | 72篇 |
2020年 | 47篇 |
2019年 | 73篇 |
2018年 | 97篇 |
2017年 | 74篇 |
2016年 | 62篇 |
2015年 | 82篇 |
2014年 | 112篇 |
2013年 | 198篇 |
2012年 | 238篇 |
2011年 | 276篇 |
2010年 | 142篇 |
2009年 | 139篇 |
2008年 | 247篇 |
2007年 | 271篇 |
2006年 | 266篇 |
2005年 | 219篇 |
2004年 | 237篇 |
2003年 | 219篇 |
2002年 | 199篇 |
2001年 | 27篇 |
2000年 | 25篇 |
1999年 | 28篇 |
1998年 | 42篇 |
1997年 | 30篇 |
1996年 | 33篇 |
1995年 | 37篇 |
1994年 | 23篇 |
1993年 | 23篇 |
1992年 | 15篇 |
1991年 | 18篇 |
1990年 | 22篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1987年 | 11篇 |
1986年 | 11篇 |
1985年 | 5篇 |
1984年 | 13篇 |
1983年 | 13篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 11篇 |
1979年 | 14篇 |
1978年 | 15篇 |
1977年 | 8篇 |
1970年 | 4篇 |
1964年 | 5篇 |
1960年 | 5篇 |
排序方式: 共有3812条查询结果,搜索用时 15 毫秒
1.
2.
3.
Lorraine Greaves Nancy Poole Natalie Hemsing 《Journal of obstetric, gynecologic, and neonatal nursing : JOGNN / NAACOG》2019,48(1):90-98
Rates of smoking during pregnancy remain high in Canada, and cessation rates are low among women who are younger than 24 years and who are socially disadvantaged, that is, have few social and economic resources because of poverty, violence, or mental health issues. On the basis of findings from literature reviews and consultation with policy makers, we developed and operationalized four approaches that can be used by health care providers to tailor interventions for tobacco use in pregnancy. These four approaches are woman centered, trauma informed, harm reducing, and equitable. Public health initiatives that address smoking in young and socially disadvantaged women could be more sharply focused by shifting to such tailored approaches that are grounded in social justice aims, span pre- and postpregnancy periods, and can be used to address women’s social contexts and concerns. 相似文献
4.
Kuo-yi Jade Chang MHealthEc MHM BSc Lisa Lorraine Dillon MSpecEd BPsych Lil Deverell COMS PhD MEd GradDipO&M BEd Mei Ying Boon PhD BOptom FAAO Lisa Keay PhD MPH BOptom 《Clinical & experimental optometry》2020,103(4):434-448
Despite orientation and mobility (O&M) being a significant factor determining quality of life of people with low vision or blindness, there are no gold standard measures or agreement on how to measure O&M performance. In the first part of this systematic review, an inventory of O&M outcome measures used by recent studies to assess the performance of orientation and/or mobility of adults with vision impairment (low vision and blindness) is presented. A wide variety of O&M outcome measures have been implemented in different fields of study, such as epidemiologic research and interventional studies evaluating training, assistive technology, vision rehabilitation and vision restoration. The most frequent aspect of outcome measures is efficiency such as time, distance, speed and percentage of preferred walking speed, followed by obstacle contacts and avoidance, and dis/orientation and veering. Other less commonly used aspects are target identification, safety and social interaction and self-reported outcome measures. Some studies employ sophisticated equipment to capture and analyse O&M performance in a laboratory setting, while others carry out their assessment in real-world indoor or outdoor environments. In the second part of this review, the appropriateness of implementing the identified outcome measures to assess O&M performance in clinical and functional O&M practice is evaluated. Nearly a half of these outcome measures meet all four criteria of face validity (either clinical or functional), responsiveness, reliability and feasibility and have the potential to be implemented in clinical or functional O&M practice. The findings of this review confirm the complicated and dynamic nature of O&M. Multiple measures are required in any evaluation of O&M performance to facilitate holistic assessment of O&M abilities and limitations of each individual. 相似文献
5.
Grace Lee Daniel W. Kim Vinayak Muralidhar Devarati Mitra Nora K. Horick Christine E. Eyler Theodore S. Hong Lorraine C. Drapek Jill N. Allen Lawrence S. Blaszkowsky Bruce Giantonio Aparna R. Parikh David P. Ryan Jeffrey W. Clark Jennifer Y. Wo 《The oncologist》2020,25(12):1015-1022
BackgroundAlthough treatment‐related lymphopenia (TRL) is common and associated with poorer survival in multiple solid malignancies, few data exist for anal cancer. We evaluated TRL and its association with survival in patients with anal cancer treated with chemoradiation (CRT).Materials and MethodsA retrospective analysis of 140 patients with nonmetastatic anal squamous cell carcinoma (SCC) treated with definitive CRT was performed. Total lymphocyte counts (TLC) at baseline and monthly intervals up to 12 months after initiating CRT were analyzed. Multivariable Cox regression analysis was performed to evaluate the association between overall survival (OS) and TRL, dichotomized by grade (G)4 TRL (<0.2k/μL) 2 months after initiating CRT. Kaplan‐Meier and log‐rank tests were used to compare OS between patients with versus without G4 TRL.ResultsMedian time of follow‐up was 55 months. Prior to CRT, 95% of patients had a normal TLC (>1k/μL). Two months after initiating CRT, there was a median of 71% reduction in TLC from baseline and 84% of patients had TRL: 11% G1, 31% G2, 34% G3, and 8% G4. On multivariable Cox model, G4 TRL at two months was associated with a 3.7‐fold increased risk of death. On log‐rank test, the 5‐year OS rate was 32% in the cohort with G4 TRL versus 86% in the cohort without G4 TRL.ConclusionTRL is common and may be another prognostic marker of OS in anal cancer patients treated with CRT. The association between TRL and OS suggests an important role of the host immunity in anal cancer outcomes.Implications for PracticeThis is the first detailed report demonstrating that standard chemoradiation (CRT) commonly results in treatment‐related lymphopenia (TRL), which may be associated with a poorer overall survival (OS) in patients with anal squamous cell carcinoma. The association between TRL and worse OS observed in this study supports the importance of host immunity in survival among patients with anal cancer. These findings encourage larger, prospective studies to further investigate TRL, its predictors, and its relationship with survival outcomes. Furthermore, the results of this study support ongoing efforts of clinical trials to investigate the potential role of immunotherapy in anal cancer. 相似文献
6.
7.
8.
9.
10.
Current clinical evidence does not support a link between TBL1XR1 and Rett syndrome: Description of one patient with Rett features and a novel mutation in TBL1XR1, and a review of TBL1XR1 phenotypes 下载免费PDF全文